Dan Stanton

Editorial director

Latest from Dan Stanton

Male being kept up at night and unable to sleep
Investment
Interest rates, IPOs, China, or Trump: What’s keeping investors up at night?Interest rates, IPOs, China, or Trump: What’s keeping investors up at night?
byDan Stanton
Feb 20, 2025
4 Min Read
Asia on a world globe
Innovation
Eyes on Asia: AZ C-suite, Verdiva and Sciwind, Korea and China at JPMEyes on Asia: AZ C-suite, Verdiva and Sciwind, Korea and China at JPM
byDan Stanton
Jan 21, 2025
5 Min Read

All from Dan Stanton

Novo Nordisk logo on a window
Business Strategy
Novo on the ‘ins and outs’ of its nucleic acid growth
Novo on the ‘ins and outs’ of its nucleic acid growth
Jan 16, 2025
|
5 Min Read
byDan Stanton, Editorial director
Image of China banknotes with a magnifying glass indicating dealmaking in Asia
Hubs
Eyes on Asia: BIOSECURE, Merck & Hansoh, Roche adds ADC, and Samsung
Eyes on Asia: BIOSECURE, Merck & Hansoh, Roche adds ADC, and Samsung
Jan 8, 2025
|
5 Min Read
byDan Stanton, Editorial director
CMO Summit in Milan, Italy
Investment
IPOs on course for recovery but does biotech need public funding anymore?
IPOs on course for recovery but does biotech need public funding anymore?
Nov 12, 2024
|
4 Min Read
byDan Stanton, Editorial director
VC/PE
'Is the worst behind us?' Financial expert talks biotech funding
'Is the worst behind us?' Financial expert talks biotech funding
Oct 21, 2024
|
7 Min Read
byBrian Scanlan, Dan Stanton

BIO-EUROPE COVERAGE

Novo Nordisk sign
Business Strategy
Lessons and blessings: The Novo Nordisk way
Lessons and blessings: The Novo Nordisk way
Michael May, PhD, President, CCRM discusses Canada as a place for life sciences in this video.
Hubs
Bridging AI & Life Sciences, Why Investing in Canada Should Be Your Next Move
Bridging AI & Life Sciences, Why Investing in Canada Should Be Your Next Move
Shaking hands
Partnering
Picky pharma prone to better proven partners amid dealmaking downturn
Picky pharma prone to better proven partners amid dealmaking downturn
Hervé Ansanay, Biotech Alliance Manager, discusses the features of the RESEAU SATT - SATT NETWORK
Sponsored Content
RESEAU SATT, the Best of French Deep Tech
RESEAU SATT, the Best of French Deep Tech

Latest

Male being kept up at night and unable to sleep
Investment
Interest rates, IPOs, China, or Trump: What’s keeping investors up at night?
Interest rates, IPOs, China, or Trump: What’s keeping investors up at night?
Asia map on the globe
Hubs
Eyes on Asia: Bain Capital buys MTPC, Merck & Co. halts HPV vax, and Illumina
Eyes on Asia: Bain Capital buys MTPC, Merck & Co. halts HPV vax, and Illumina
Francesco De Rubertis, co-founder and partner at Medicxi (left) and Graziano Seghezzi, managing partner at Sofinnova Partners (right).
Investment
Sofinnova and Medicxi talk M&A, patent cliffs, and China
Sofinnova and Medicxi talk M&A, patent cliffs, and China
Mar 17 - Mar 19, 2025
Europe's Largest Springtime Biotech Partnering Event
REGISTER
Subscribe to Our Newsletters
Stay updated and receive your insights for life sciences investment, innovation and partnering directly in your inbox.
Stay Updated